Invizius

Invizius

Pharmaceutical Manufacturing Bo'ness Road, United Kingdom 12 employees
Employees
12
Contacts
1
Emails
1

Invizius Overview

Headquarters
Bo'ness Road, United Kingdom
Website
invizius.com
Industry
Pharmaceutical Manufacturing
Employees
12
Founded
2018
Funding
1.3M
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Invizius

Invizius is a spin-out based on world-class Complement research carried out at the University of Edinburgh, Scotland. Complement is 1.3b years old and part of the innate immune system. As it is the most ancient part of the immune system it is involved at the beginning of every inflammatory response. We fight inflammation at its source. Invizius is developing Second Generation Complement Therapeutics to significantly improve the clinical outcomes of patients with dysregulated complement systems leading to inflammation and fibrosis. Our first indication for H-Guard is in Acute Kidney Injury receiving CRRT where there is filter membrane associated Complement driven damage to renal tubule cells as well as local and systemic inflammatory damage. Our second product Meso-Guard is for patients on Renal replacement Therapy receiving Peritoneal Dialysis. This product should extend the PD treatment window by reducing fibrotic changes caused by peritoneal dialysis fluid. Despite significant improvements in haemodialysis membranes Complement activation by contact with a foreign surface remains a serious issue with short, medium and long term clinical implications. Other acute application of H-Guard is for coating Cardiopulmonary Bypass and ECMO filters. Other applications of our platform include IgA Nephropathy, Preeclampsia, SLE and Neuroinflammation.

Invizius Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

Invizius Org Chart

Sample employees and titles
Name Title Contact
Joanna Anderson Quality Assurance Manager at Ingenza
View
Maria Moffat Finance Manager
View
Dr Magnus Nicolson Chief Executive Officer @ Invizius - Developing Complement Therapeutics
Email
Dr. Sandra Neumann Senior Vice President, Global Operations, Ferring Pharmaceuticals Experienced Executive with Broad Experience in Pharma, Medtech and Commercial
View

Employees by Management Level

Executive 2 profiles
Manager 2 profiles
Individual contributor 2 profiles

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Invizius Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Invizius